No Detail Found!

Determination of prevalence of cardiovascular complications in end-stage renal failure patients

Author(s)
Arief Mohammad Department of Clinical Pharmacy, UCSI University,Kuala Lumpur,Malaysia
Harika Bheemaravapu Department of Pharmaceutical Analysis, Tallapadmavathi College of Pharmacy, Warangal, Telangana, India,
Iizhar Ahmed Syed Department of Pharmacy, Ibn Sina National college, Jeddah, KSA
Muhammad Junaid Farrukh Department of Clinical Pharmacy, UCSI University,Kuala Lumpur,Malaysia
Abstract
Introduction: It is estimated that about 40-50% of all deaths in the end-stage renal disease patients are of cardiovascular origin. Myocardial infarction (MI), congestive heart failure (CHF), and angina are the three major cardiovascular diseases associated with end-stage renal failure. The aim of this study is to determine the prevalence of cardiovascular complications in end-stage renal failure patients. Subjects and Methods: A retrospective cohort study was designed to determine the development of complications in end-stage renal failure patients admitted to a tertiary care hospital in Andhra Pradesh, India from January 2012 to June 2015. The mean standard deviation was determined for all categorical variables, and further data analysis was carried out using SPSS software version 20. Results: A total of 190 chronic kidney disease (CKD) patients were included in this study. Of 190 patients, 38.42% were smokers while 66.32%, 69.67%, and 56.48% of them had diabetes, hypertension, and hyperlipidemia, respectively. The percentage of end-stage renal failure patients who developed MI, CHF, and angina were 40%, 21.58%, and 12.11%, respectively while a Framingham risk score =30% was recorded in 38.42% patients. Conclusion: This study shows that chronic renal failure accelerates cardiovascular complications, and it is more prominent in patients who have predetermined traditional risk factors such as hypertension, dyslipidemia, and smoking. Prevention and treatment of cardiovascular complications are major considerations in the management of individuals with CKD.
Publication Details
Page(s) 158-165
Published Journal: Archives of Pharmacy Practice, Volume: 7, Issue: 4, Year: 2016

Request the full text from PASTIC

Keywords
Smoking Cessation, Diabetes, Cardiovascular complications, Diabetes, Hyperlipidemia, Chronic Kidney Disease, Framingham risk score
References
Anavekar NS,Pfeffer MA .2004 .Cardiovascular risk in chronic kidney disease. Kidney Int Suppl, : S11-5.
.2011 .Management of chronic kidney disease in adults. Malaysian clinical practice guideline. , 1 : 1-58.
Fernandez‑ Fresnedo G,Rodrigo E,de Castro SS,Castañeda O,Arias M. .2006 .Role of pulse pressure on cardiovascular risk in chronic kidney disease patients. J the American Society of Nephrology, 17(12 suppl 3) : S246-9.
Wannamethee SG,Shaper AG,Perry IJ .1997 .Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. Stroke, 28 : 557-63.
Go AS,Fang MC,Udaltsova N,Chang Y,Pomernacki NK,Borowsky L .2009 .Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation, 119 : 1363-9.
Sarnak MJ,Levey AS,Schoolwerth AC,Coresh J,Culleton B,Hamm LL .2003 .Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 108 : 2154-69.
Menon V,Gul A,Sarnak MJ A .2005 .Cardiovascular risk factors in chronic kidney disease. Kidney Int, 68 : 1413-8.
Weiner DE,Tabatabai S,Tighiouart H,Elsayed E,Bansal N,Griffith J .2006 .Cardiovascular outcomes and all‑cause mortality: Exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis, 48 : 3924-01.
Orth SR,Hallan SI .2008 .Smoking: A risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients - Absence of evidence or evidence of absence?. Clin J Am Soc Nephrol, 3 : 226-36.
Yacoub R,Habib H,Lahdo A,Al Ali R,Varjabedian L,Atalla G .2010 .Association between smoking and chronic kidney disease: A case control study. BMC Public Health, 10 : 731.
Weiner DE,Tighiouart H,Elsayed EF,Griffith JL,Salem DN,Levey AS .2007 .The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol, 50 : 217-24.
Hwang HS,Choi YA,Kim SY,Cho WK,Nam Y,Kim SJ .2015 .Diabetes retinopathy is a poor predictor for renal and cardiovascular outcomes in comparison with hypertensive retinopathy in patients with chronic kidney disease. Diabetes Res Clin Pract, 109 : 312-8.
Currie CJ,Peters JR,Tynan A,Evans M,Heine RJ,Bracco OL .2010 .Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet, 375 : 481-9.
Foley RN,Murray AM,Li S,Herzog CA,McBean AM,Eggers PW .2005 .Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol, 16 : 489-95.
Longenecker JC,Coresh J,Powe NR,Levey AS,Fink NE,Martin A .2002 .Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study. J Am Soc Nephrol, 13 : 1918-27.
Nakano T,Ninomiya T,Sumiyoshi S,Fujii H,Doi Y,Hirakata H .2010 .Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: The Hisayama study. Am J Kidney Dis, 55 : 21-30.
Chonchol M,Whittle J,Desbien A,Orner MB,Petersen LA,Kressin NR .2008 .Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol, 28 : 354-60.
Marwick TH,Steinmuller DR,Underwood DA,Hobbs RE,Go RT,Swift C .1990 .Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end‑stage renal failure. Transplantation, 49 : 100-3.
Joki N,Hase H,Nakamura R,Yamaguchi T. .1997 .Onset of coronar y arter y disease prior to initiation of haemodialysis in patients with end‑stage renal disease. Nephrol Dial Transplant, 12 : 718-23.
Ohtake T,Kobayashi S,Moriya H,Negishi K,Okamoto K,Maesato K .2005 .High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol, 16 : 1141-8.
deFilippi C,Wasserman S,Rosanio S,Tiblier E,Sperger H,Tocchi M .2003 .Cardiac troponin T and Cr‑eactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long‑term hemodialysis. JAMA, 290 : 353-9.
Herzog CA,Asinger RW,Berger AK,Charytan DM,Díez J,Hart RG .2011 .Cardiovascular disease in chronic kidney disease. Kidney Int, 80 : 572-86.
Fleischmann EH,Bower JD,Salahudeen AK .2001 .Are conventional cardiovascular risk factors predictive of two‑year mortality in hemodialysis patients?. Clin Nephrol, 56 : 221-30.
Anderson KM,Wilson PW,Odell PM,Kannel WB .1991 .An updated coronary risk profile. A statement for health professionals. Circulation, 83 : 356-62.
Wilson PW,D'Agostino RB,Levy D,Belanger AM,Silbershatz H,Kannel WB H .1998 .Prediction of coronary heart disease using risk factor categories. Circulation, 97 : 1837-47.
Churchill DN,Taylor DW,Cook RJ,LaPlante P,Barre P,Cartier P .1992 .Canadian hemodialysis morbidity study. Am J Kidney Dis, 19 : 214-34.
Stack AG,Bloembergen WE .2001 .Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross‑sectional study. J Am Soc Nephrol, 12 : 1516-23.
Parfrey PS,Foley RN .1999 .The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol, 10 : 1606-15.
Kiberd B. .2006 .The chronic kidney disease epidemic: Stepping back and looking forward. J Am Soc Nephrol, 17 : 2967-73.
White SL,Cass A,Atkins RC,Chadban SJ .2005 .Chronic kidney disease in the general population. Adv Chronic Kidney Dis, 12 : 5-13.
Dirks JH,De Zeeuw D,Agar wal SK,Atkins RC,Correa‑Rotter R,D'Amico G .2005 .Prevention of chronic kidney and vascular disease: toward global health equitythe Bellagio 2004 Declaration. International, 68 : S1-6.
Perico N,Codreanu I,Schieppati A,Remuzzi G. .2005 .The future of renoprotection. Kidney International, 68 : S951-01.
Jungers P,Massy ZA,Nguyen Khoa T,Fumeron C,Labrunie M,Lacour B .1997 .Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant, 12 : 2597-602.
Shlipak MG,Fried LF,Cushman M,Manolio TA,Peterson D,Stehman‑Breen C .2005 .Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA, 293 : 1737-45.
Cheung AK,Sarnak MJ,Yan G,Dwyer JT,Heyka RJ,Rocco MV .2000 .Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney International, 58(1) : 353-62.
Brunzel JD,Goldberg AP .1977 .. , : 336-41.
Middleton JP,Pun PH .2010 .Hypertension, chronic kidney disease, and the development of cardiovascular risk: A joint primacy. Kidney Int, 77 : 753-5.
Paoletti E,Specchia C,Di Maio G,Bellino D,Damasio B,Cassottana P .2004 .The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey. Nephrol Dial Transplant, 19 : 1829-34.
Cavanaugh KL .2007 .Diabetes management issues for patients with chronic kidney disease. Clinical Diabetes, 25 : 90-7.
Ali AB,Elsayed A,Baloshi HA,Ansari AA .2013 .Right atrial thrombus post haemodialysis catheter: Case reports. Int J Med Sci Public Health, 2 : 680-2.
Schwab SJ,Beathard G. .1999 .The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int, 56 : 1-17.
Li PK,Szeto CC,Piraino B,Bernardini J,Figueiredo AE,Gupta A .2010 .Peritoneal dialysis‑related infections recommendations: 2010 update. Perit Dial Int, 30 : 393-423.
0

Citations

0

Downloads

9

Views